Streetbeat News

Stock Prices

O

A significant investor has taken a bullish stance on Realty Income (NYSE:O), with unusual options activity detected. The trades are evenly split between bullish and bearish expectations. The total amount for puts is $208,432 and for calls is $266,870. Whales have been targeting a price range from $40.0 to $60.0 for Realty Income over the last 3 months. The current price of O is up 0.36% at $47.55. B of A Securities and Mizuho have both given a Neutral rating with price targets of $52 and $48 respectively.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 5:47 pm

SGEN

A significant bearish stance has been taken on Seagen (NASDAQ:SGEN) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $190.0 to $220.0 for Seagen over the last 3 months. Currently, the price of SGEN is up 0.66% at $214.22. Truist Securities downgraded its action to Hold with a price target of $229.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 5:46 pm

UNM

Unum Group's shares are trading lower following the company's Q3 earnings report, which showed a year-over-year decrease in EPS and lower-than-expected sales.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:45 pm

MCY

OSCR

ROOT

Insurance stocks saw significant movement during Wednesday's intraday session. Gainers included Mercury General (MCY), FG Finl Gr (FGFPP and FGF), Kingstone Companies (KINS), Citizens (CIA), and Brighthouse Finl (BHFAP). Losers included Oscar Health (OSCR), Huize Holding (HUIZ), Cheche Group (CCG), Bright Health Gr (BHG), Hallmark Financial Servs (HALL), and Root (ROOT).

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 5:40 pm

CYTK

Cytokinetics Inc (NASDAQ:CYTK), a biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options after garnering interest from at least one major pharmaceutical company. The company is currently assessing its next course of action. Potential suitors may wait until Cytokinetics releases data from an upcoming Phase 3 trial before pursuing any acquisition. The company's shares are down 0.34% at $34.74.

Portfolio Pulse from Vandana Singh

November 01, 2023 | 5:38 pm

SITE

SiteOne Landscape Supply reported mixed Q3 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:38 pm

NCLH

Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) reported Q3 FY23 sales growth of 57% YoY to $2.536 billion, beating the analyst consensus. Adjusted EPS of $0.76 also beat the consensus of $0.69. However, the company predicts a loss in Q4 due to new waves of disruptions, with an expected adjusted EPS of ~$(0.15) vs consensus of $0.01. NCLH shares are trading lower by 3.13% at $13.17.

Portfolio Pulse from Akanksha Bakshi

November 01, 2023 | 5:37 pm

SSRM

SSR Mining reported mixed Q3 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:37 pm

CMRE

Costamare Inc reported Q3 FY23 Voyage revenue growth of 37.2% YoY to $397.34 million, beating consensus of $310.53 million. However, its adjusted EPS was $0.46, missing the consensus of $0.66. The company repurchased 882,316 common shares for a total of $10 million during the quarter. Costamare's shares are trading lower by 5.20% at $8.56.

Portfolio Pulse from Akanksha Bakshi

November 01, 2023 | 5:37 pm

ANET

Arista Networks reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:35 pm